|
Orthologous residues
|
|
Ig‑alpha (human): Y210‑p, Ig‑alpha (mouse): Y204‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mass spectrometry, mutation of modification site, peptide sequencing
|
|
Disease tissue studied:
lymphoma, B cell lymphoma
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
anti-IgM
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
BLNK (mouse)
|
SH2
|
Induces
|
phosphorylation
|
|
pull-down assay
|
|